Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

The Syringa Hospital and Clinics Diabetes Support group meets from 3-4 p.m. at the Soltman Center on the following dates with the topics listed: ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City ...

It’s well known that diet and exercise is important, but many people may not know how managing glucose levels can significantly enhance overall health and well-being. Nutrition expert, ...

This study presents a noninvasive biosensor that measures glucose levels through sweat, providing an alternative to ...